Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
The new facility offers an expanded laboratory alongside meeting areas dedicated to development meetings, formulation workshops, and brainstorming sessions
The move strengthens GBL’s clinical-stage presence in the United States
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
LANXESS Biosecurity Solutions aims to deliver “advanced disinfection and hygiene solutions to support Indian farmers in maintaining healthier and safer farm environments
Subscribe To Our Newsletter & Stay Updated
